CB Chubb (CB) Insider Trading, Ownership & Congress Trades
Insurance · Fire, marine & casualty insurance · CIK 0000896159
Congress · 4Form 144 · 3
Insider buyers, 180 days
0
Funds added, last quarter
1,033
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · $540.2K priced
What the filings say about CB
Insiders, 180 days
-$13.8M net sold
5 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
4 bought · 4 sold
Latest: sale, 2026-09-24
Planned sales (Form 144), 90 days
$11.5M
3 notices
Chubb insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Chubb Ltd insiders sold a net $13.8M of stock across 133 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 43.0% of the 12,803 shares held after it.
- 1 other insider sold within 30 days.
- 1,033 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director CONNORS MICHAEL P sold about $1.9M of CB on Aug 21, 2026; 1 other insider sold within 30 days and 1,033 funds added in the latest 13F quarter.Context
- 12 earlier Form 4 trades (code P or S) here by this insider (12 sales), the last on Mar 3, 2026.
- The trade is 25.2% of the 33,749 shares held after it.
- 1 other insider sold within 30 days.
- 1,033 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Vice President and* Wayland Joseph F sold about $3.1M of CB on Jul 28, 2026; 1 other insider sold within 30 days and 1,033 funds added in the latest 13F quarter.Context
- 8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Dec 2, 2025.
- The trade is 13.5% of the 28,858 shares held after it.
- 2 other insiders sold within 30 days.
- 1,033 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Vice President* Ortega Juan Luis sold about $1.3M of CB on Jun 8, 2026; 2 other insiders sold within 30 days and 1,033 funds added in the latest 13F quarter.Context
- 12 earlier Form 4 trades (code P or S) here by this insider (1 buy, 11 sales), the last on Jun 6, 2025.
- The trade is 9.8% of the 206,145 shares held after it.
- 2 other insiders sold within 30 days.
- 1,033 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President &COO Keogh John W sold about $6.5M of CB on May 27, 2026; 2 other insiders sold within 30 days and 1,033 funds added in the latest 13F quarter.Context
- 12 earlier Form 4 trades (code P or S) here by this insider (1 buy, 11 sales), the last on Jun 6, 2025.
- The trade is 1.4% of the 203,321 shares held after it.
- 2 other insiders sold within 30 days.
- 1,033 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President &COO Keogh John W sold about $909.2K of CB on May 27, 2026; 2 other insiders sold within 30 days and 1,033 funds added in the latest 13F quarter.133 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$13.8M over 180 days
-$1.9M over 90 days
below 78% of Insurance
Congress
4 members bought in the last year
more than 94% of Insurance
Funds
1,033 funds bought in last quarter
more than 98% of Insurance
Revenue
+6.5% year over year
below 59% of Insurance
Margin
17.4% net margin
more than 66% of Insurance
Buybacks
$1.2B repurchased, FY to 2026-03-31
more than 89% of Insurance
Short interest
0.9% of the float short (float per yahoo 2026-10-26) · 1.8 days to cover · settled 2026-09-30
below 85% of Insurance
What changed in the last 30 days
Oct 26Officer BOROUGHS TIMOTHY ALAN filed to sell $4.9M by Oct 26 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 23Officer GREENBERG EVAN G filed to sell $4.7M by Oct 23 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 13Rep. Kevin Hern sold $1.0K to $15K, disclosed 20 days after the trade
Why it matters
House members report a bracket, not an exact amount, and have 45 days to do it; the trade is weeks old when it becomes public.
Oct 7Rep. Maria Elvira Salazar sold $1.0K to $15K, disclosed 13 days after the trade
Why it matters
House members report a bracket, not an exact amount, and have 45 days to do it; the trade is weeks old when it becomes public.
Watch CB
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+29.2%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CB: institutional holders (13F)
13F holdings, latest reported quarter
34,249,183 sh
$11.7B
29,093,549 sh
$9.9B
23,177,820 sh
$7.9B
16,727,420 sh
$5.7B
13,368,929 sh
$4.6B
Congress trades in CB
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2026-09-24 · disclosed 13 days later
$1,001 - $15,000
Sold 2026-09-23 · disclosed 20 days later
$1,001 - $15,000
Bought 2026-08-31 · disclosed 25 days later
$1,001 - $15,000
Sold 2026-08-19 · disclosed 21 days later
$15,001 - $50,000
Bought 2026-07-01 · disclosed 37 days later
$15,001 - $50,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CB planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
BOROUGHS TIMOTHY ALAN
Filed 2026-10-26
$4.9M
GREENBERG EVAN G
Filed 2026-10-23
$4.7M
CONNORS MICHAEL P
Filed 2026-08-21
$1.9M
Wayland Joseph F
Filed 2026-07-28
$3.1M
CB mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
iShares U.S. Insurance ETF
$55.4M position · as of 2026-06-30
13.1%
Invesco KBW Property & Casualty Insurance ETF
$19.3M position · as of 2026-05-31
8.0%
Davis Financial Portfolio
$2.8M position · as of 2026-06-30
4.8%
Davis Financial Fund
$55.5M position · as of 2026-06-30
4.8%
Liberty One Defensive Dividend Growth ETF
$2.9M position · as of 2026-07-31
4.8%
WEDGEWOOD FUND
$1.2M position · as of 2026-06-30
4.5%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Evan G. Greenberg
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$27.7M
$35.7M
$7.9M
+57%
+42%
2022
$25.2M
$44.2M
$8.1M
+50%
+34%
2021
$23.2M
$42.0M
$7.0M
+30%
+15%
2020
$20.3M
$14.6M
$6.7M
+1%
-6%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $13.8M sold by insiders over 180 days, 1,033 funds added last quarter, 4 House member(s) bought in 12 months, disclosed weeks after the trade, $11.5M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
CB financials
Revenue growth
+6.5%
XBRL, annual
Net margin
17.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$60.8B
four quarters, 2025-04-01 to 2026-03-31
Revenue, TTM CB
| FY Dec 2025 | $59.4B |
| FY Dec 2024 | $55.8B |
| FY Dec 2023 | $49.7B |
| FY Dec 2022 | $43.2B |
| FY Dec 2021 | $41.0B |
| Mar 2026 | $14.8B |
| Dec 2025 | $15.1B |
| Sep 2025 | $16.1B |
| Jun 2025 | $14.8B |
| Mar 2025 | $13.4B |
| Dec 2024 | $14.2B |
| Sep 2024 | $14.8B |
| Jun 2024 | $13.8B |
At each fiscal year end
Single quarter
Net margin, TTM
+18.6%
net income over revenue, 2025-04-01 to 2026-03-31
Net margin, TTM CB
| FY Dec 2025 | +17.4% |
| FY Dec 2024 | +16.6% |
| FY Dec 2023 | +18.2% |
| FY Dec 2022 | +12.2% |
| FY Dec 2021 | +20.8% |
| Mar 2026 | +15.7% |
| Dec 2025 | +21.3% |
| Sep 2025 | +17.3% |
| Jun 2025 | +20.0% |
| Mar 2025 | +10.0% |
| Dec 2024 | +18.2% |
| Sep 2024 | +15.7% |
| Jun 2024 | +16.1% |
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM CB
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
0.24x
long-term 2026-03-31 plus current 2026-03-31; equity 2026-03-31
Debt to equity CB
| FY Dec 2025 | 0.23x |
| FY Dec 2024 | 0.24x |
| FY Dec 2023 | 0.24x |
| FY Dec 2022 | 0.29x |
| FY Dec 2021 | 0.28x |
| Mar 2026 | 0.24x |
| Dec 2025 | 0.23x |
| Sep 2025 | 0.24x |
| Jun 2025 | 0.22x |
| Mar 2025 | 0.22x |
| Dec 2024 | 0.24x |
| Sep 2024 | 0.25x |
| Jun 2024 | 0.24x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.87x
TTM operating cash flow over long-term 2026-03-31 plus current 2026-03-31
Cash flow to debt CB
| FY Dec 2025 | 0.74x |
| FY Dec 2024 | 1.07x |
| FY Dec 2023 | 0.87x |
| FY Dec 2022 | 0.76x |
| FY Dec 2021 | 0.69x |
| Mar 2026 | 0.87x |
| Dec 2025 | 0.74x |
| Sep 2025 | 0.77x |
| Jun 2025 | 0.93x |
| Mar 2025 | 1.00x |
| Dec 2024 | 1.07x |
| Sep 2024 | 0.92x |
| Jun 2024 | 1.03x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+16.2%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on equity CB
| FY Dec 2025 | +15.0% |
| FY Dec 2024 | +15.0% |
| FY Dec 2023 | +16.4% |
| FY Dec 2022 | +9.6% |
| FY Dec 2021 | +14.5% |
| Mar 2026 | +16.2% |
| Dec 2025 | +15.0% |
| Sep 2025 | +14.1% |
| Jun 2025 | +14.1% |
| Mar 2025 | +13.4% |
| Dec 2024 | +15.0% |
| Sep 2024 | +16.9% |
| Jun 2024 | +17.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.3%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets CB
| FY Dec 2025 | +4.0% |
| FY Dec 2024 | +3.9% |
| FY Dec 2023 | +4.2% |
| FY Dec 2022 | +2.6% |
| FY Dec 2021 | +4.4% |
| Mar 2026 | +4.3% |
| Dec 2025 | +4.0% |
| Sep 2025 | +3.7% |
| Jun 2025 | +3.7% |
| Mar 2025 | +3.5% |
| Dec 2024 | +3.9% |
| Sep 2024 | +4.2% |
| Jun 2024 | +4.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CB
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CB
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.55x
close 2026-10-23 over four quarters of diluted EPS, 2025-04-01 to 2026-03-31
P/E, trailing CB
| FY Dec 2025 | 12.14x |
| FY Dec 2024 | 12.17x |
| FY Dec 2023 | 10.36x |
| FY Dec 2022 | 17.83x |
| FY Dec 2021 | 10.06x |
| Mar 2026 | 11.52x |
| Dec 2025 | 12.14x |
| Sep 2025 | 11.78x |
| Jun 2025 | 12.79x |
| Mar 2025 | 14.54x |
| Dec 2024 | 12.17x |
| Sep 2024 | 11.82x |
| Jun 2024 | 10.79x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$152.9B
market value at close 2026-10-23 on 2026-04-21 shares, plus long-term 2026-03-31 plus current 2026-03-31, minus cash 2023-06-30
Enterprise value CB
| FY Dec 2025 | $137.8B |
| FY Dec 2024 | $124.3B |
| FY Dec 2023 | $104.4B |
| FY Dec 2022 | $104.4B |
| FY Dec 2021 | $97.8B |
| Mar 2026 | $142.3B |
| Dec 2025 | $137.8B |
| Sep 2025 | $127.5B |
| Jun 2025 | $128.8B |
| Mar 2025 | $133.1B |
| Dec 2024 | $124.3B |
| Sep 2024 | $130.3B |
| Jun 2024 | $116.0B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield CB
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.35x
P/E over trailing EPS growth of 36%: four quarters to 2026-03-31 against the four to 2025-03-31
PEG, trailing CB
| FY Dec 2025 | 0.92x |
| FY Dec 2024 | 2.95x |
| FY Dec 2023 | 0.14x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 0.07x |
| Mar 2026 | 0.32x |
| Dec 2025 | 0.92x |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | 2.95x |
| Sep 2024 | 0.27x |
| Jun 2024 | 0.15x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $59.4B | $55.8B | $49.7B | $43.2B |
| Net income | $10.3B | $9.3B | $9.0B | $5.2B |
| EPS (diluted) | 25.68 | 22.70 | 21.80 | 12.39 |
| Operating cash flow | $12.8B | $16.2B | $12.6B | $11.3B |
| Cash | n/a | n/a | n/a | $2.0B |
| Long-term debt | $15.7B | $14.4B | $13.0B | $14.4B |
| Buybacks | $3.7B | $1.8B | $2.4B | $2.9B |
| Dividends paid | $1.5B | $1.4B | $1.4B | $1.4B |
SEC XBRL, fiscal years, as known on 2026-10-27
CB Stock Sonar score 6/7 axes
Find similar shapesCompareCB ranks highest on risk and compliance (79th percentile) and institutional and government (69th), and lowest on insider conviction (9th), among Insurance peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CB filings, in plain words
Are Chubb insiders buying or selling CB?
In the 180 days to 2026-10-27, Chubb insiders were net sellers, a net $13.8M across purchases and sales reported on Form 4, by 5 sellers.
Have members of Congress traded CB?
Yes. In the year to 2026-10-27, 4 House members disclosed buying CB and 4 House members disclosed selling it; the latest on record is a sale by Maria Elvira Salazar dated 2026-09-24.
Are there planned insider sales of CB?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $11.5M of stock; the latest, by BOROUGHS TIMOTHY ALAN, was filed 2026-10-26.
Read the full summary
In the 180 days to 2026-10-27, Chubb insiders were net sellers of CB, a net $13.8M across purchases and sales reported on Form 4 by 5 sellers. None of the 6 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-27, 4 members of Congress disclosed buying CB and 4 members disclosed selling it; the latest on record is a sale by Maria Elvira Salazar dated 2026-09-24. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $11.5M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
